What is Orkambi
Approved as Treatment by the FDA
Lumacaftor, otherwise known as Orkambi, is approved by the FDA for 1 uses such as Cystic Fibrosis (CF) .Effectiveness
When to interrupt dosage
The advised measure of Orkambi is contingent upon the determined disorder. The amount of dosage fluctuates as per the delivery methodology (e.g. Granule - Oral or Granule) noted in the table beneath.Warnings
Orkambi ContraindicationsOrkambi Novel Uses: Which Conditions Have a Clinical Trial Featuring Orkambi?
One active trial is examining the effectiveness of Orkambi in relieving symptoms associated with Cystic Fibrosis (CF).Orkambi Reviews: What are patients saying about Orkambi?
Patient Q&A Section about orkambi
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What are the side effects of Orkambi?
"The following are some of the common side effects that may occur when taking this medication: breathing problems such as shortness of breath and chest tightness; nausea; diarrhea; fatigue; increase in a certain blood enzyme called creatine phosphokinase; rash; gas; and the common cold, including sore throat, stuffy or runny nose."
How effective is Orkambi?
"Orkambi, a lumacaftor/ivacaftor combination, can improve overall health in adolescents and adults with cystic fibrosis. However, the study found that its use can be risky for those who do not tolerate the therapy."
What does the drug Orkambi do?
"These cells are also responsible for sweeping bacteria and other particles out of the lungs.
Orkambi is a medicine used to treat cystic fibrosis in patients aged 2 years and above. Cystic fibrosis is an inherited disease that has severe effects on the lungs and the digestive system. It affects the cells that produce mucus and digestive juices. These cells are also responsible for sweeping bacteria and other particles out of the lungs."
What is the difference between Orkambi and Trikafta?
"Trikafta is a three-drug combination of ivacaftor, tezacaftor and elexacaftor (previously coded as VX-445). Symdeko is a two-drug combination of ivacaftor and tezacaftor, while Orkambi is a combination of ivacaftor with lumacaftor."
How much does Orkambi cost?
"The list prices for Orkambi and Symdeko are around $272,000 and $292,000 respectively. Analysts expect that the early approval of Trikafta will lead to an acceleration of its launch date, with the drug expected to make $630 million in 2020."
What is Orkambi used for?
"ORKAMBI is a prescription medicine that is used to treat cystic fibrosis in patients that are 1 year old or older and have two copies of the F508del mutation in their CFTR gene."